Skip to content Skip to navigation

Solodyn Anti-Competition Settlement

Share
Active: 
Closed
Closed Settlement Statement: 
According to court documents, the claim submission deadline has passed. Please contact the claims administrator if you have any questions.
Settlement Structure: 
Case Summary: 

The final two defendants in a class action have agreed to settle a class action alleging that a group of companies engaged in anti-competitive behavior. The complaint alleges that Medicis Pharmaceutical Corp.(“Medicis”), Impax Laboratories, Inc., Lupin Limited, Lupin Pharmaceuticals Inc., and Sandoz Inc. unlawfully settled patent lawsuits covering the drug Solodyn. The result of this was a delay in the availability of generic equivalents, causing consumers to pay more for treatment. Previously, Lupin Limited, Lupin Pharmaceuticals Inc., and Sandoz Inc. settled; now Medicis and Impax are settling.

Docket Number: 
1:14-md-2503-DJC
Company: 
Impax
Class Period: 
Thursday, July 23, 2009 to Sunday, February 25, 2018
Filing Deadline: 
Tuesday, July 31, 2018
Objection Deadline: 
Monday, June 18, 2018
Final Approval Hearing: 
Wednesday, July 18, 2018
Bottles of Solodyn